Chronic obstructive pulmonary disease (COPD) exacerbations and oral corticosteroid use dropped in patients treated with monoclonal antibodies targeting interleukin (IL)-5 and its receptor (IL-5R), a study found.
to medication supply. it s very frustrating and really a combination between conflict issues and acute exacerbations. redepend on raw materials from china and india. slow regulatory, lack of transparency regarding supply. and then also increased use. what if something we saw over the winter we saw we had a lot of medications, antibiotics, ibuprofen in short supply. why was that because people were using them a lot more because of weakened immune systems coming out of the pandemic. now let s look at some of these cancer medications that are in short supply. it s very similar in the sense that cancer diagnoses were down 25% the last few years because of the covid-19 pandemic. people weren t going and getting their cancer treatments, their screenings. and now here we are we are having more cancer diagnoses and we are finding these medications in short supply. we have to do more than we can to manufacture these medications in the united states and have increased transparency with their reg
last week when a manufacturing plant suddenly shut down. let s discuss what this means for patients out there with cnn p analyst dr. jonathan reinert. what does albuterol do? jim, albuterol is an old drug. it was licensed by the fda for use in the united states in 1982. it s it s what s called a bronco dilator. it allows the airways to dilate. it s the primary drug used for acute exacerbations of asthma. the and it comes in a couple different forms. it comes in inhalers that people can use at home and it comes in a liquid form that is used in nebulizers when people are admitted to hospitals with serious asthma exacerbations.
A new study conducted by Keisuke Anan and team showed that in individuals with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF), early corticosteroid dosage lowering was linked to a good.